Impact of FFR After Stenting: Useful or Mere Fun Fact?

Suboptimal fractional flow reserve (FFR) results after stenting only have a moderate impact on clinical hard points but might predict a much higher risk of reintervention.

Impacto del FFR post stent ¿dato útil o solo una curiosidad?

FFR has shown a huge impact on the decision-making process when it comes to revascularizing (or not) a lesion. Its impact after angioplasty has not been fully studied, particularly in the long term. We know the thresholds before angioplasty, but should there be target values after that procedure? If FFR does not improve as much as we expected after stenting, should it be optimized, somehow?

This large-scale study included all patients who underwent FFR-guided angioplasty.

FFR was measured immediately after angioplasty and then once the operator considered the outcome as acceptable and final. These results were only observational, since no action was taken based on them.

A suboptimal result was defined as final FFR <0.90. The final endpoint was a composite of cardiac death, infarction, and any revascularization after a 2-year follow-up.

With 1000 patients included and 1165 vessels analyzed, FFR after angioplasty was <0.9 in 440 vessels (37.8%). Almost 400 patients left the cath lab with at least one vessel whose FFR was suboptimal. This accounts for over a third of the procedures; its frequency is surprising. We should remember that no action was taken based on these results.


Read also: FREEDOM with FFR: Different Outcomes?


The analysis per patient did not show a significant association between FFR results after angioplasty and combined events after 2 years of follow-up (hazard ratio [HR]: 1.08, 95% confidence interval [CI]: 0.73 to 1.60; p = 0.707). Upon consideration of each event separately, no association was found either.

The analysis per vessel offered different results. FFR <0.9 after angioplasty was associated with almost twice as many target-vessel revascularizations (HR: 1.91; 95% CI: 1.06 to 3.44; p = 0.030) and a higher risk for thrombosis.

Conclusion

Suboptimal FFR after angioplasty had no significant impact on hard cardiovascular events, but it was associated with almost twice as many target-vessel revascularizations.

CIRCINTERVENTIONS-120-009681FREE

Original Title: Impact of Poststenting Fractional Flow Reserve on Long-Term Clinical Outcomes. The FFR-SEARCH Study.

Reference: Roberto Diletti et al. Circ Cardiovasc Interv. 2021;14:e009681. DOI: 10.1161/CIRCINTERVENTIONS.120.009681.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...